A growing body of evidence associates CPT1A with the malignant progression of various cancers, for CPT1A may participate in the regulation of intracellular neutral lipid content, which is associated with the genesis of aggressive forms of cancers [13]. The gene discussed is CPT1A; the disease is cancer.